Menu
Recruiting NCT07605169

Long-term Health and Economic Effects of an Individualized Lifestyle Intervention (LI-PAD-Extended)

No phase Interventional Overweight Obesity Prediabetic State

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Individualized physical activity and diet.
Who it may be relevant to
Registry conditions: Overweight, Obesity, Prediabetic State. Basic parameters: 45 years — 65 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Sweden
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Long-term Follow-up of Individualized Lifestyle Intervention Focused on Physical Activity and Diet: Effects on Weight Loss, Dietary Habits, Cardiovascular Health, Motivation, Health-related Quality of Life, and Health Economics (LI-PAD-Extended)

Overview

The goal of this clinical trial is to learn if an individualized lifestyle intervention works to improve weight, diet, physical activity, cardiovascular health, health-related quality of life, and cost-effectiveness in overweight and obese adults aged 45-65 years. The main questions it aims to answer are: Does the intervention lead to sustained weight loss after 18 months? Does the intervention improve cardiovascular risk factors, metabolic markers, and health-related quality of life compared to general written advice? Is the intervention cost-effective? Researchers will compare the individualized lifestyle intervention to a control group that receives general written advice on physical activity and diet to see if the intervention provides greater long-term health and economic benefits. Participants will: Attend counseling sessions with a health promoter Take part in supervised aerobic and resistance training with a physiotherapist Use swimming facilities and participate in the Lifestyle School Access a digital health coach and the online Lifestyle Tool Complete measurements of body weight, diet, physical activity, and cardiovascular health markers (waist-to-hip ratio, blood pressure, blood lipids, fasting glucose, HbA1c, CRP, and liver enzymes) Complete assessments of resting energy expenditure, aerobic fitness, muscle strength, motivation, and health-related quality of life Provide blood samples at baseline, 6 months, and 18 months for dietary biomarker analysis Contribute data for health economic evaluation to assess cost-effectiveness

Detailed description

Background Overweight and obese adults, especially those with type 2 diabetes, have increased risk of cardiovascular disease (CVD). Lifestyle interventions with physical activity (PA) and diet improve CVD risk factors, but long-term behavior change is challenging. Individualized approaches are recommended, yet rarely implemented for both PA and diet in clinical practice.

Objectives

The study evaluates whether an individualized precision health intervention:

Produces greater weight loss at 6 months (short-term) and 18 months (long-term)

Improves cardiovascular risk factors, metabolic markers, diet, PA behaviors, fitness, and psychosocial outcomes

Is feasible and cost-effective compared to standard lifestyle advice

Study Design

Randomized controlled trial with two arms:

Intervention group: Individualized precision health program

Control group: Standard lifestyle advice

Total participants: 120 (60 per group), aged 45-65 years, BMI 28-34

Exclusion: known coronary artery disease, inability to participate in lifestyle interventions, or language barriers

Intervention (LI-PAD Precision Health):

Step 1: Individual Adaptation

Adjust recommendations for medical conditions, comorbidities, medications, psychosocial factors, preferences, readiness to change, and barriers/facilitators

Step 2: Individualized Advice

PA prescription based on accelerometry, VO₂max, and muscle strength

Dietary guidance based on food intake diaries and measured resting energy expenditure (REE)

Step 3: Support for Goal Achievement

Education and skill training

Behavioral support: health promoters, group sessions, face-to-face and online coaching, apps for diet and PA, nudging

Control Group:

Standard lifestyle advice: healthy diet, ≥300 min/week moderate-intensity aerobic PA, 2 sessions/week strength training

Outcome Measures:

Primary Outcome:

Change in body weight from baseline to 6 months and 18 months

Secondary Outcomes:

BMI, waist and hip circumference

Blood pressure

Blood markers: cardiometabolic (lipids, HbA1c, cholesterol, HDL, LDL; ASAT, ALAT, ALP, GGT, hs-CRP) and dietary intake biomarkers

Cardiorespiratory fitness and muscle strength

Behavioral measures: PA (accelerometry, SGPALS), diet (MiniMeal-Q, REE)

Psychosocial outcomes: health-related quality of life (EQ5D-3L, RAND-36), motivation, self-efficacy

Cost-effectiveness analysis based on BMI and secondary outcomes

Additional Outcomes (Intervention Group):

Feasibility: attendance, compliance, participant evaluation

Barriers and facilitators to behavioral change

GPS tracking of PA and dietary behavior

Assessments:

Baseline, 6-month, and 18-month follow-ups

Interventions

  • Behavioral Individualized physical activity and diet
    Precision health

Primary outcome measures

  • Body Weight Change [Time frame: Baseline, 6 months, 18 months]
Secondary outcome measures (12)
  • Change in Body Mass Index (BMI) [Time frame: Baseline, 6 months, 18 months.]
  • Change in Systolic Blood Pressure [Time frame: Baseline, 6 months, 18 months]
  • Change in Waist Circumference [Time frame: Baseline, 6 months, 18 months]
  • Change in Hip Circumference [Time frame: Baseline, 6 months, 18 months]
  • Change in Total Cholesterol [Time frame: Baseline, 6 months, 18 months]
  • Change in HDL Cholesterol [Time frame: Baseline, 6 months, 18 months]
  • Change in LDL Cholesterol [Time frame: Baseline, 6 months, 18 months]
  • Change in Triglycerides [Time frame: Baseline, 6 months, 18 months]
  • Change in HbA1c [Time frame: Baseline, 6 months, 18 months]
  • Change in Aspartate Aminotransferase (ASAT) [Time frame: Baseline, 6 months, 18 months]
  • Change in Alanine Aminotransferase (ALAT) [Time frame: Baseline, 6 months, 18 months]
  • Change in High-Sensitivity C-Reactive Protein (hs-CRP) [Time frame: Baseline, 6 months, 18 months]

Eligibility criteria

Inclusion criteria

  • Adults aged 45-65 years at baseline of the original LI-PAD study
  • Body mass index (BMI) ≥28 and ≤34
  • Completed the original LI-PAD study
  • Able and willing to attend follow-up assessments and provide necessary data
  • Able and willing to provide informed consent

Exclusion criteria

  • Known coronary artery disease (clinical symptoms or earlier event)
  • Inability to understand the language used in the study
  • Inability to complete follow-up assessments at 18 months
  • Severe illness or medical condition that, in the investigator's opinion, precludes participation in follow-up assessments

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Open label
Primary purpose
Prevention

Study locations

Sweden · 1 center
  • Centre for Lifestyle Intervention — Gothenburg

Identifiers

NCT: NCT07605169 · LI-PAD EXTENDED · 285373

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗